The Turnover for the quarter ended September 2022 of Rs. 209.43 millions increase by 74.82% from Rs. 119.80 millions.The Net Loss for the quarter ended September 2022 is Rs. -40.62 millions as compared to Net Loss of Rs. -108.49 millions of corresponding quarter ended September 2021 Operating profit Margin for the quarter ended September 2022 improved to -16.27% as compared to -76.57% of corresponding quarter ended September 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 209.43 119.80 74.82 315.84 187.35 68.58 597.03 537.00 11.18
Other Income 2.75 1.32 108.33 4.04 1.62 149.38 11.56 6.21 86.15
PBIDT -16.27 -76.57 -78.75 -77.66 -141.53 -45.13 -328.39 -169.56 93.67
Interest 7.42 17.76 -58.22 10.46 32.88 -68.19 53.91 62.79 -14.14
PBDT -23.69 -94.33 -74.89 -88.12 -174.41 -49.48 -382.30 -232.35 64.54
Depreciation 16.93 14.16 19.56 33.86 28.32 19.56 62.97 51.24 22.89
PBT -40.62 -108.49 -62.56 -121.98 -202.73 -39.83 -445.27 -283.59 57.01
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -40.62 -108.49 -62.56 -121.98 -202.73 -39.83 -445.27 -283.59 57.01
Equity 215.61 215.61 0.00 215.61 215.61 0.00 215.61 196.21 9.89
PBIDTM(%) -7.77 -63.91 -87.85 -24.59 -75.54 -67.45 -55.00 -31.58 74.20

Krebs Biochem.&Inds Share Price

70.49 1.37 (1.98%)
26-Dec-2025 14:48 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1267.60
Cipla 1508.60
Zydus Lifesciences 909.90
Lupin 2110.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×